Search Results 111-120 of 17247 for fibrosis quistica

1. Efficacy And Safety Of SAR156597 In The Treatment Of Idiopathic Pulmonary Fibrosis - Mayo Clinic

   ... Fibrosis (IPF). Secondary Objectives: To evaluate the efficacy of 2 dose levels of SAR156597 compared to placebo on IPF disease progression. To evaluate the ...

2. Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) - Mayo Clinic

   Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) ... fibrosis, as assessed histologically (via liver biopsy).

3. A Study to Compare BAL CD8+ TRM Cells and Lung Fibrosis Scores in COVID-19 Infection Survivors - Mayo Clinic

   The purpose of this study is to correlate BAL CD8+ TRM cells and quantitative lung fibrosis scores in survivors of moderate-to-severe COVID-19 infection.

4. Pediatric diabetes / new cystic fibrosis medication / thoracic surgery - Mayo Clinic News Network

   Pediatric diabetes / new cystic fibrosis medication / thoracic surgery. March 14, 2020. Related Episodes. Memory testing and gender / adult cochlear implants ...

5. A Study Evaluating The Efficacy And Safety Of Pegozafermin In Participants With MASH And Fibrosis (ENLIGHTEN-Fibrosis) - Mayo Clinic

   The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult ...

6. Noninvasive Evaluation of Renal Allograft Fibrosis by MRI - Mayo Clinic

   The purpose of this study is to validate an MRI method to detect renal fibrosis in patients after kidney transplantation (KT). Participation eligibility.

7. A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

   Systemic Sclerosis (SSc) is a devastating disease of unknown etiology. Patients suffer from multiple organ fibrosis whereas lung fibrosis (interstitial lung ...

8. Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns and current practices - Mayo Clinic

   Pirfenidone and nintedanib are approved for treatment of idiopathic pulmonary fibrosis (IPF), but questions remain regarding indications and timing of ...

9. Fibrocystic breasts - Symptoms and causes - Mayo Clinic

   Fluid-filled round or oval sacs (cysts); A prominence of scar-like fibrous tissue (fibrosis); Overgrowth of cells (hyperplasia) lining the milk ducts or milk- ...

10. A Study to Evaluate PRM-151 in Patients with Idiopathic Pulmonary Fibrosis - Mayo Clinic

    ... fibrosis (IPF). Specific objectives and corresponding endpoints for the study are outlined below. Participation eligibility. Participant eligibility includes ...